All Outputs (4)

The development of small-scale, low-cost biofilm treatment systems for the control of pathogens in fresh water (2023)
Thesis
Steven, J. The development of small-scale, low-cost biofilm treatment systems for the control of pathogens in fresh water. (Thesis). University of the West of England. Retrieved from https://uwe-repository.worktribe.com/output/10274632

Water that is contaminated with pathogenic microorganisms, can cause disease. Despite advances in the provision of safe drinking water, an estimated 580 million people lack consistent access to safe water whilst the consumption of biologically contam... Read More about The development of small-scale, low-cost biofilm treatment systems for the control of pathogens in fresh water.

Clean water for all (2022)
Digital Artefact
Clayton, G., Steven, J., Thorn, R., & Reynolds, D. (2022). Clean water for all. [Website]

The World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF) estimated that, as of 2020, 2 billion people across the globe did not have access to safely managed drinking water. Ideally, safely managed drinking water should b... Read More about Clean water for all.

The control of waterborne pathogenic bacteria in fresh water using a biologically active filter (2022)
Journal Article
Steven, J. A. C., Thorn, R. M. S., Robinson, G. M., Turner, D., Lee, J. E., & Reynolds, D. M. (2022). The control of waterborne pathogenic bacteria in fresh water using a biologically active filter. npj Clean Water, 5(1), 30. https://doi.org/10.1038/s41545-022-00169-y

The aim of this study was to investigate the control of three species of bacteria commonly associated with biologically contaminated water, using biofiltration. In this study, a laboratory-scale biofilter system was used to investigate the control of... Read More about The control of waterborne pathogenic bacteria in fresh water using a biologically active filter.

Rapid in vitro testing and characterization of resistance to chemotherapeutic agents daunorubicin and cytarabine in acute myeloid leukaemia (2017)
Journal Article
May, J., Steven, J., Taylor, A., Dean, S., & Anderson, E. (2017). Rapid in vitro testing and characterization of resistance to chemotherapeutic agents daunorubicin and cytarabine in acute myeloid leukaemia. Mutagenesis, 32(6), 627. https://doi.org/10.1093/mutage/gex033

Treatment success in leukaemia is impacted by patient resistance to chemotherapy including cytarabine (ara-C) and the anthracycline daunorubicin (DNR) requiring rapid pre-screening testing. DNR is converted to daunorubicinol (DNRol) by carbonyl reduc... Read More about Rapid in vitro testing and characterization of resistance to chemotherapeutic agents daunorubicin and cytarabine in acute myeloid leukaemia.